Recent years, anti-tumor therapeutic vaccines have been developed as an active strategy to specifically recognize and destroy malignant cells by inducing CTL responses and CD3+CD4+ T helper cell activation relying on tumor antigens. The gene discussed is CD4; the disease is neoplasm.